Chungcheongbuk-do, South Korea

Yeon Joo Choi


Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yeon Joo Choi: Innovator in Protein Transduction Domains

Introduction: Yeon Joo Choi is a distinguished inventor hailing from Chungcheongbuk-do, South Korea. With a focus on biotechnological innovations, he has made significant strides in developing compounds that enhance the delivery of therapeutic agents within living organisms.

Latest Patents: Yeon Joo Choi holds a patent for a "Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound." This invention introduces a protein transduction domain and a fusion compound that are designed to be more efficient. The research led to the identification of the GK1 peptide, which is composed of 18 amino acids. This peptide can bond effectively to high-molecular-weight materials like proteins, allowing for improved penetration into cells, tissues, or blood. The applications of this invention are substantial, as it can be utilized as a pharmaceutical composition aimed at preventing or treating various diseases.

Career Highlights: Yeon Joo Choi is currently associated with Genesen Co., Ltd., where he leverages his expertise in biotechnology to push the boundaries of pharmaceutical science. His pioneering work in the field has not only contributed to advancing medical therapies but also underscores the importance of innovative approaches in drug delivery systems.

Collaborations: Throughout his career, Yeon Joo Choi has collaborated with fellow researchers such as Soo-Young Choi and Jin-Seu Park. These collaborations have facilitated the sharing of knowledge and resources, leading to breakthroughs in the development of more effective therapeutic strategies.

Conclusion: Yeon Joo Choi exemplifies the spirit of innovation in the biotechnological field. His contributions, particularly in creating more effective protein transduction domains and fusion compounds, represent significant advancements in the pharmaceutical industry. His work continues to inspire future research and innovation aimed at improving health outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…